Lv2
120 积分 2023-12-01 加入
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
13天前
已完结
PT101: A Treg selective agonist IL-2 mutein therapy for autoimmunity
25天前
已关闭
AP2M1 as the potential biomarker for prediction of the response of atopic dermatitis to Dupilumab therapy: Multi-omics analysis and evidence
25天前
已完结
Molecular imaging supports the development of multispecific cancer antibodies
1个月前
已完结
Eliminating IgE reverses allergy
1个月前
已完结
Non-specificity as the sticky problem in therapeutic antibody development
1个月前
已完结
AIntibody: an experimentally validated in silico antibody discovery design challenge
2个月前
已完结
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab
3个月前
已完结
New insights into antibody structure with implications for specificity, variable region restriction and isotype choice
3个月前
已完结
Concurrent intratumoural Treg cell depletion and CD8+ T cell expansion via a cleavable anti-4-1BB–interleukin-15 fusion protein
4个月前
已完结
皖公网安备34019202002308
